Biotech CRO InvitroCue Executive director Dr. Steven Fang explains how their technology has disrupted the current clinical trials landscape and the importance of leveraging innovative technologies in meeting future healthcare needs.
Could you please introduce to our international readers the main activities of InvitroCue as well as the milestones since its foundation in 2012?
"[Digital pathology is a great solution for developing countries such as China and India where healthcare access is a challenge ... [it] offers a cheap, fast and accurate solution, based on scalable artificial intelligence technology."
